Dr. Svendsen brings extensive research experience in medical biochemistry, synthetic organic chemistry and medicinal chemistry, specializing in antibacterial peptides. Dr. Svendsen received his PhD from the University of Tromsø, and has been visiting scientist at several distinguished international institutions, including in the laboratory of Professor K.B. Sharpless (Nobel Laureate, Chemistry, 2000) at Massachusetts Institute of Technology. He is a Professor of organic chemistry in the Faculty of Sciences at the University of Tromsø.  Dr. Svendsen is also a co-founder and board member of Lytix Biopharma AS, a Norwegian pharmaceutical company focusing on cancer immunotherapy.